US3674836A
(en)
*
|
1968-05-21 |
1972-07-04 |
Parke Davis & Co |
2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof
|
US4027009A
(en)
*
|
1973-06-11 |
1977-05-31 |
Merck & Co., Inc. |
Compositions and methods for depressing blood serum cholesterol
|
JPS5612114B2
(de)
*
|
1974-06-07 |
1981-03-18 |
|
|
NO154918C
(no)
*
|
1977-08-27 |
1987-01-14 |
Bayer Ag |
Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
|
US4231938A
(en)
*
|
1979-06-15 |
1980-11-04 |
Merck & Co., Inc. |
Hypocholesteremic fermentation products and process of preparation
|
DE2951135A1
(de)
*
|
1979-12-19 |
1981-06-25 |
Hoechst Ag, 6230 Frankfurt |
Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
|
DK149080C
(da)
*
|
1980-06-06 |
1986-07-28 |
Sankyo Co |
Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
|
US4450171A
(en)
*
|
1980-08-05 |
1984-05-22 |
Merck & Co., Inc. |
Antihypercholesterolemic compounds
|
US4448784A
(en)
*
|
1982-04-12 |
1984-05-15 |
Hoechst-Roussel Pharmaceuticals, Inc. |
1-(Aminoalkylphenyl and aminoalkylbenzyl)-indoles and indolines and analgesic method of use thereof
|
US5354772A
(en)
*
|
1982-11-22 |
1994-10-11 |
Sandoz Pharm. Corp. |
Indole analogs of mevalonolactone and derivatives thereof
|
JPS6051189A
(ja)
*
|
1983-08-30 |
1985-03-22 |
Sankyo Co Ltd |
チアゾリジン誘導体およびその製造法
|
DE3543999A1
(de)
*
|
1985-12-13 |
1987-06-19 |
Bayer Ag |
Hochreine acarbose
|
US4681893A
(en)
*
|
1986-05-30 |
1987-07-21 |
Warner-Lambert Company |
Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
|
US4759923A
(en)
*
|
1987-06-25 |
1988-07-26 |
Hercules Incorporated |
Process for lowering serum cholesterol using poly(diallylmethylamine) derivatives
|
JP2569746B2
(ja)
*
|
1987-08-20 |
1997-01-08 |
日産化学工業株式会社 |
キノリン系メバロノラクトン類
|
US4871721A
(en)
*
|
1988-01-11 |
1989-10-03 |
E. R. Squibb & Sons, Inc. |
Phosphorus-containing squalene synthetase inhibitors
|
US4924024A
(en)
*
|
1988-01-11 |
1990-05-08 |
E. R. Squibb & Sons, Inc. |
Phosphorus-containing squalene synthetase inhibitors, new intermediates and method
|
NO177005C
(no)
*
|
1988-01-20 |
1995-07-05 |
Bayer Ag |
Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen
|
US5753675A
(en)
*
|
1989-03-03 |
1998-05-19 |
Novartis Pharmaceuticals Corporation |
Quinoline analogs of mevalonolactone and derivatives thereof
|
FI94339C
(fi)
*
|
1989-07-21 |
1995-08-25 |
Warner Lambert Co |
Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
|
US5177080A
(en)
*
|
1990-12-14 |
1993-01-05 |
Bayer Aktiengesellschaft |
Substituted pyridyl-dihydroxy-heptenoic acid and its salts
|
JP2648897B2
(ja)
*
|
1991-07-01 |
1997-09-03 |
塩野義製薬株式会社 |
ピリミジン誘導体
|
GB9209628D0
(en)
*
|
1992-05-05 |
1992-06-17 |
Smithkline Beecham Plc |
Compounds
|
US5470845A
(en)
*
|
1992-10-28 |
1995-11-28 |
Bristol-Myers Squibb Company |
Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia
|
LT3300B
(en)
|
1992-12-23 |
1995-06-26 |
Schering Corp |
Combination of a cholesterol biosynhtesis inhibitor and a beta- lactam cholesterol absorbtion inhibitor
|
US5594016A
(en)
*
|
1992-12-28 |
1997-01-14 |
Mitsubishi Chemical Corporation |
Naphthalene derivatives
|
US5662934A
(en)
|
1993-01-05 |
1997-09-02 |
Najarian; Thomas |
Compositions and methods for lowering cholesterol while maintaining antioxidant levels
|
CA2150372C
(en)
*
|
1993-01-19 |
2002-08-20 |
Nancy L. Mills |
Stable oral ci-981 formulation and process of preparing same
|
US5776983A
(en)
*
|
1993-12-21 |
1998-07-07 |
Bristol-Myers Squibb Company |
Catecholamine surrogates useful as β3 agonists
|
US5488064A
(en)
*
|
1994-05-02 |
1996-01-30 |
Bristol-Myers Squibb Company |
Benzo 1,3 dioxole derivatives
|
US5385929A
(en)
*
|
1994-05-04 |
1995-01-31 |
Warner-Lambert Company |
[(Hydroxyphenylamino) carbonyl] pyrroles
|
US5612359A
(en)
*
|
1994-08-26 |
1997-03-18 |
Bristol-Myers Squibb Company |
Substituted biphenyl isoxazole sulfonamides
|
US5491134A
(en)
*
|
1994-09-16 |
1996-02-13 |
Bristol-Myers Squibb Company |
Sulfonic, phosphonic or phosphiniic acid β3 agonist derivatives
|
US5541204A
(en)
*
|
1994-12-02 |
1996-07-30 |
Bristol-Myers Squibb Company |
Aryloxypropanolamine β 3 adrenergic agonists
|
US5698527A
(en)
|
1995-08-08 |
1997-12-16 |
Merck & Co., Inc. |
Steroidal glycosides as antihyperlipidemic agents
|
CA2240024A1
(en)
|
1995-12-13 |
1997-06-19 |
The Regents Of The University Of California |
Nuclear receptor ligands and ligand binding domains
|
US6107300A
(en)
*
|
1996-03-27 |
2000-08-22 |
Dupont Pharmaceuticals |
Arylamino fused pyrimidines
|
IL117702A0
(en)
|
1996-03-28 |
1996-07-23 |
Tel Aviv Medical Center Resear |
Drug for hyperlipoproteinemia
|
US5770615A
(en)
*
|
1996-04-04 |
1998-06-23 |
Bristol-Myers Squibb Company |
Catecholamine surrogates useful as β3 agonists
|
ZA973884B
(en)
*
|
1996-05-23 |
1998-11-06 |
Du Pont Merck Pharma |
Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
|
DE19622222A1
(de)
|
1996-06-03 |
1997-12-04 |
Hoechst Ag |
Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikament zur Normalisierung der Serumlipide
|
US6537987B1
(en)
|
1996-06-20 |
2003-03-25 |
Pfizer Inc. |
4,1-benzoxazepines or 4,1-benzothiazepines and their use as squalene synthetase inhibitors
|
HRP970330B1
(en)
|
1996-07-08 |
2004-06-30 |
Bayer Ag |
Cycloalkano pyridines
|
US6191131B1
(en)
*
|
1997-07-23 |
2001-02-20 |
Dupont Pharmaceuticals Company |
Azolo triazines and pyrimidines
|
TW536540B
(en)
*
|
1997-01-30 |
2003-06-11 |
Bristol Myers Squibb Co |
Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
|
GB9713739D0
(en)
|
1997-06-27 |
1997-09-03 |
Karobio Ab |
Thyroid receptor ligands
|
CN1268137A
(zh)
*
|
1997-07-03 |
2000-09-27 |
杜邦药品公司 |
治疗神经失调的咪唑并嘧啶和咪唑并吡啶
|
US6635626B1
(en)
*
|
1997-08-25 |
2003-10-21 |
Bristol-Myers Squibb Co. |
Imidazoquinoxaline protein tyrosine kinase inhibitors
|
DE69807085D1
(de)
*
|
1997-09-02 |
2002-09-12 |
Bristol Myers Squibb Pharma Co |
Heterocyclyl-substituierte annellierte pyridine und pyrimidine als antagonisten des corticotropin freisetzenden hormons (crh), verwendbar für die behandlung von cns und stress
|
KR100666887B1
(ko)
|
1997-10-08 |
2007-01-10 |
상꾜 가부시키가이샤 |
치환 축합 복소환 화합물
|
ZA991301B
(en)
|
1998-02-18 |
1999-09-13 |
Neurosearch As |
Glutamate receptor modulators.
|
WO1999045009A1
(en)
*
|
1998-03-04 |
1999-09-10 |
Bristol-Myers Squibb Company |
Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
|
US6365589B1
(en)
*
|
1998-07-02 |
2002-04-02 |
Bristol-Myers Squibb Pharma Company |
Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
|
CA2336714A1
(en)
|
1998-07-06 |
2000-01-13 |
Bristol-Myers Squibb Company |
Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
|
AU5612199A
(en)
|
1998-09-10 |
2000-04-03 |
Forbes Medi-Tech Inc. |
Compositions comprising one or more phytosterols, phytostanols or mixtures of both and one or more alpha, beta, delta, or gamma tocotrienols or derivatives thereof and use of the compositions in treating or preventing cardiovascular disease, its underlying conditions and other
|
US6147089A
(en)
|
1998-09-17 |
2000-11-14 |
Pfizer Inc. |
Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines
|
DE69912833T2
(de)
|
1998-11-25 |
2004-09-23 |
Nutri Pharma Asa |
Zusammensetzung enthaltend sojaprotein, diätfasern und phytoestrogen sowie ihre verwendung zur vorbeugung und/oder behandlung von kardiovaskulären erkrankungen
|
JP2002531549A
(ja)
*
|
1998-12-04 |
2002-09-24 |
ブリストル−マイヤーズ スクイブ カンパニー |
カリウムチャネル・モジュレーターとしての3−置換−4−アリールキノリン−2−オン誘導体
|
AU2157400A
(en)
|
1998-12-23 |
2000-07-31 |
G.D. Searle & Co. |
Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications
|
US6271380B1
(en)
*
|
1998-12-30 |
2001-08-07 |
Dupont Pharmaceuticals Company |
1H-imidazo[4,5-d]pyridazin-7-ones, 3H-imidazo-[4,5-c]pyridin-4-ones and corresponding thiones as corticotropin releasing factor (CRF) receptor ligands
|
AU776785B2
(en)
|
1999-02-24 |
2004-09-23 |
Johns Hopkins University, The |
Compositions and methods for modulating serum cholesterol
|
US6329051B1
(en)
*
|
1999-04-27 |
2001-12-11 |
Albany International Corp. |
Blowable insulation clusters
|
US6414002B1
(en)
*
|
1999-09-22 |
2002-07-02 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
PH12000002657B1
(en)
*
|
1999-10-12 |
2006-02-21 |
Bristol Myers Squibb Co |
C-aryl glucoside SGLT2 inhibitors
|
US6515117B2
(en)
*
|
1999-10-12 |
2003-02-04 |
Bristol-Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
US6395767B2
(en)
*
|
2000-03-10 |
2002-05-28 |
Bristol-Myers Squibb Company |
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
|
US6630476B2
(en)
*
|
2000-07-07 |
2003-10-07 |
Bristol-Myers Squibb Pharma Company |
Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists
|
JP2004532792A
(ja)
|
2000-07-14 |
2004-10-28 |
ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー |
神経障害を治療するためのイミダゾ[1,2−a]ピラジン
|
EP1320365A4
(de)
*
|
2000-09-21 |
2004-03-17 |
Bristol Myers Squibb Co |
Substituierte azolderivate als hemmer des corticotropin-freisetzungsfaktors
|
JP4225787B2
(ja)
|
2001-03-27 |
2009-02-18 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
N−アリール環状アミン誘導体およびそれを有効成分として含有する医薬
|
EP1375479A1
(de)
|
2001-04-06 |
2004-01-02 |
Eisai Co., Ltd. |
Pyrrolidinderivat und verfahren zu dessen herstellung
|
US6573287B2
(en)
*
|
2001-04-12 |
2003-06-03 |
Bristo-Myers Squibb Company |
2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
|
CN1642599A
(zh)
|
2002-02-27 |
2005-07-20 |
辉瑞产品公司 |
Acc抑制剂
|
EP1471066A1
(de)
*
|
2003-04-24 |
2004-10-27 |
Aventis Pharma Deutschland GmbH |
Triaza- und Tetraaza-anthrazendionderivate, ihre Herstellung und Verwendung als Pharmazeutika
|